GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution

Rapid weight loss can lead to issues with bone quality, particularly in older adults.

CryptoHub · Oct 8, 2026 · 6 views

GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution

Some of the millions of Americans taking a GLP-1 drug to lose weight are getting an unexpected benefit: Their back and knee pain is getting better.

Doctors who specialize in back and knee pain say that some patients are showing up in their clinics with anecdotes about less pain and better mobility after losing weight while taking medications like Novo Nordisk’s DK:NOVO.B NVO Wegovy or Eli Lilly’s LLY Zepbound.

Business

BlackRock's Fink names a U.S. recession trigger, sounds alarm over $40 trillion national debt

BlackRock's CEO says "a moratorium of some sort" on data center buildouts would put the U.S. in a recession.

Oct 15, 2026

Business

Anthropic’s $2 Trillion IPO Pitch Meets a Revenue Growth Slowdown

Anthropic reportedly earned $1.70 in revenue for every $1 it spent on computing power in the third quarter. The artificial intelligence (AI) company shared the figure with investors weeks before its planned November initial public offering…

Oct 15, 2026

Business

Ripple’s Korean Expansion Reaches From Remittances to Government Bonds

Ripple’s Korean partnerships now connect cross-border business payments, bank-managed digital asset wallets, and blockchain-based settlement of government bonds. Its cooperation with Meritz Securities extends that strategy into capital mar…

Oct 15, 2026

Business

Peter Schiff Says Most Stocks Are in Bear Market as AI Leaders Carry the Index

Peter Schiff says most stocks are in a bear market as 479 hit 52-week lows. Goldman data shows AI leaders carry the S&P 500.

Oct 15, 2026

GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution

Related

BlackRock's Fink names a U.S. recession trigger, sounds alarm over $40 trillion national debt

Anthropic’s $2 Trillion IPO Pitch Meets a Revenue Growth Slowdown

Ripple’s Korean Expansion Reaches From Remittances to Government Bonds

Peter Schiff Says Most Stocks Are in Bear Market as AI Leaders Carry the Index